Molecular therapy for Myocardial Infarction: Long ncRNA HULC ((H ighly U pregulated in L iver C ancer)) inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction via up-regulation of PNUTS, 15/February/2017, 11.15 pm

Natural product therapy for Diabetic Kidney disease: Shikonin, isolated from Zicao (also known as Purple gromwell), decreases VEGF-B expression, inhibits lipid accumulation in Podocytes, promotes insulin signalling in Podocytes, induces insulin sensitivity, ameliorates renal dysfunction and alleviates diabetic kidney disease via down regulation of its target gene, 15/February/2017, 11.07 pm
February 15, 2017
Natural product-derived therapy for glucose homeostasis and TIIDM: Oleanolic acid, isolated from Java apple, Olive Europaea, and Phytolacca americana among others, inhibits Amysin expression, increases insulin secretion, and decreases the risk of hyperglycemia via down regulation of its target gene Sox4, 16/February/2017, 9.17 am
February 16, 2017
Show all

What they say

A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published in the 7 March  2013 issue of Nature  by Prof Dimmler, Boon, and others.


What we say

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  Molecular therapy for Myocardial Infarction:  Long ncRNA HULC  ((H ighly U pregulated in L iver C ancer)inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction via  up-regulation of PNUTS


From Significance of the study to Public Health relevance:

Given that: (1)  cardiovascular disease is the leading cause of death worldwide; (2) the raise of death rate, due to cardiovascular disease, has increased from  123 lakhs in 1990 to 173 lakhs in 2013; (3) 85% of people over 80 years are susceptible to cardiovascular diseases;(4) in India, in 2004, 14.6 lakhs deaths (14% of total deaths) were due to ischemic heart disease; (3) the death due to cardiovascular disease is higher in low-to-middle income countries compared to developed countries; (4) the global economic cost spent in the treatment of cardiovascular disease in 2011 was little more than 10 billion US dollars; (5) an alarming number of people, such as 230 lakhs people, will die from cardiovascular diseases each year by 2030, there is an urgent need to find: (i) a way to induce regeneration of cardiomyocytes that were lost in Myocardial patients; (ii) a cheaper alternative to the existing expensive drugs; and (iv) a side-effect-free Natural product-based drug.


From Research Findings to Therapeutic Opportunity

This study provides an RNA-based therapy for myocardial infarction. Long ncRNA HULC, by increasing the expression of its target genes, it may increase the expression of PNUTS (figs.1-2) . Thereby, it may: (1) inhibit DNA damage responses, (2) increase telomerase expression, (3) inhibit telomere shortening; (4) promote cardiomyocyte survival/regeneration; (5) decelerate ageing; and (6) extend life span (fig 1). 

price-300

Thus, by treating myocardial patients with  Long ncRNA HULC, one may prevent ageing-associated (or, stress-associated) decline in cardiac function. Together, this study suggests that pharmacological formulations encompassing  Long ncRNA HULC or its activators or   Long ncRNA HULC in combination with any of the known drugs that improve myocardial function”  may be used to improve cardiac function after myocardial infarction (fig. 3) 

[easy_payment currency=”USD”]

HULC increases PNUTS expression

Figure 1. Long ncRNA HULC functions as a Cardioprotective agent. Mechanistic insights into how Long ncRNA HULC induces the expression PNUTS and Telomerase to promote Cardiac regeneration/survival


Details of the research findings

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed information: How   Long ncRNA HULC  increases the expression of PNUTS and Telomerase

Amount: $300#

# Research cooperation

For purchase and payment details, you may reach us at admin@genomediscovery.org


References:

Web:http://genomediscovery.org or http://newbioideas.com/

CitationBoominathan, L.,   Molecular therapy for Myocardial Infarction:  Long ncRNA HULC  ((H ighly U pregulated in L iver C ancer)) inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction via  up-regulation of PNUTS, 15/February/2017, 11.15 pm,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at admin@genomediscovery.org

Comments are closed.